Reply

Affiliations

Comment

Jeffrey A Berinstein et al. Clin Gastroenterol Hepatol. 2021 Jun.

. 2021 Jun;19(6):1303-1304.

doi: 10.1016/j.cgh.2020.08.023. Epub 2020 Nov 26.

¹ Gastroenterology and Hepatology, University of Michigan , Ann Arbor, Michigan.

No abstract available

Comment on

Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis.
Berinstein JA, Steiner CA, Regal RE, Allen JI, Kinnucan JAR, Stidham RW, Waljee AK, Bishu S, Aldrich LB, Higgins PDR. Berinstein JA, et al. Clin Gastroenterol Hepatol. 2019 Apr;17(5):988-990.e1. doi: 10.1016/j.cgh.2018.11.022. Epub 2018 Nov 17. Clin Gastroenterol Hepatol. 2019. PMID: 30458248 Free PMC article.
Tofacitinib Is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis.
Gilmore R, Hilley P, Srinivasan A, Choy MC, Grace JA, de Cruz P. Gilmore R, et al. Clin Gastroenterol Hepatol. 2021 Jun;19(6):1302-1303. doi: 10.1016/j.cgh.2020.07.046. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248087 No abstract available.